Patents by Inventor Erik Jan Van Den Berg

Erik Jan Van Den Berg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECOMBINANT ALKALINE PHOSPHATASE FOR USE IN TREATING ACUTE RESPIRATORY DISTRESS SYNDROME
    Publication number: 20240009280
    Abstract: The present disclosure relates to the use of alkaline phosphatases, and in particular improved alkaline phosphatases such as RecAP, for the prevention, treatment, cure, or amelioration of the symptoms of acute respiratory distress syndrome (ARDS). The application relates to methods of preserving lung function, shortening the duration of mechanical ventilation therapy, increasing a the P/F ratio.
    Type: Application
    Filed: September 9, 2021
    Publication date: January 11, 2024
    Inventors: Jeroen ELASSAISS-SCHAAP, Erik Jan VAN DEN BERG
  • Chimeric alkaline phosphatase-like proteins
    Patent number: 11746340
    Abstract: The invention relates to improved alkaline phosphatases, pharmaceutical compositions comprising improved alkaline phosphatases and the use of improved alkaline phosphatases for preventing, treating or curing diseases.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: September 5, 2023
    Assignee: AM-PHARMA B.V.
    Inventors: Willem Raaben, Luigi Johannes Cornelius Jonk, Erik Jan Van Den Berg, Andrea Van Elsas, José Luis Millán
  • CHIMERIC ALKALINE PHOSPHATASE-LIKE PROTEINS
    Publication number: 20210163905
    Abstract: The invention relates to improved alkaline phosphatases, pharmaceutical compositions comprising improved alkaline phosphatases and the use of improved alkaline phosphatases for preventing, treating or curing diseases.
    Type: Application
    Filed: October 16, 2020
    Publication date: June 3, 2021
    Inventors: Willem RAABEN, Luigi Johannes Cornelius Jonk, Erik Jan Van Den Berg, Andrea Van Elsas, José Luis MILLÁN
  • RECOMBINANT ALKALINE PHOSPHATASE FOR USE IN TREATING SEPSIS-ASSOCIATED ACUTE KIDNEY INJURY
    Publication number: 20200397870
    Abstract: The present disclosure relates to the use of alkaline phosphatases, and in particular improved alkaline phosphatases such as RecAP, for the prevention, treatment, cure, or amelioration of the symptoms of acute kidney injury caused, e.g., by sepsis. The application relates to methods of preserving renal function renal function, shortening the duration of renal replacement therapy, increasing the creatinine clearance, decreasing the risk of death in subjects with sepsis-associate acute kidney injury (SA-AKI) or at risk of SA-AKI.
    Type: Application
    Filed: March 8, 2019
    Publication date: December 24, 2020
    Inventors: Roelof Peter PICKKERS, Ravindra Lall MEHTA, Partick Thomas MURRAY, Michael JOANNIS, Erik Jan VAN DEN BERG, Jacques Salomon Robert AREND
  • Chimeric alkaline phosphatase-like proteins
    Patent number: 10822597
    Abstract: The invention relates to improved alkaline phosphatases, pharmaceutical compositions comprising improved alkaline phosphatases and the use of improved alkaline phosphatases for preventing, treating or curing diseases.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: November 3, 2020
    Assignee: AM-Pharma B.V.
    Inventors: Willem Raaben, Luigi Johannes Cornelius Jonk, Erik Jan Van Den Berg, Andrea Van Elsas, José Luis Millán
  • Downstream Processing of an Alkaline Phosphatase
    Publication number: 20200063112
    Abstract: The invention relates to the field of downstream processing (DSP) of an alkaline phosphatase (AP). More specifically, it relates to a method for reducing host cell protein content in a composition comprising AP. The invention further relates to a composition comprising an AP and a reduced content of a host cell protein.
    Type: Application
    Filed: September 4, 2019
    Publication date: February 27, 2020
    Applicant: AM-Pharma B.V.
    Inventors: Luigi Johannes Cornelius JONK, Stephen Edward CONNOR, Erik Jan VAN-DEN BERG, Andrea VAN ELSAS, Abhinav Alok SHUKLA, Heather Bethea HORNE, Susan COOK, Timothy Martin KELLY, Victoria Anne DOWLING, Mialy Fanjamalala RAMAROSON
  • Downstream processing of an alkaline phosphatase
    Patent number: 10570380
    Abstract: The invention relates to the field of downstream processing (DSP) of an alkaline phosphatase (AP). More specifically, it relates to a method for reducing host cell protein content in a composition comprising AP. The invention further relates to a composition comprising an AP and a reduced content of a host cell protein.
    Type: Grant
    Filed: January 26, 2015
    Date of Patent: February 25, 2020
    Assignee: AM-PHARMA B.V.
    Inventors: Luigi Johannes Cornelius Jonk, Stephen Edward Connor, Erik Jan Van Den Berg, Andrea Van Elsas, Abhinav Alok Shukla, Heather Bethea Horne, Susan Cook, Timothy Martin Kelly, Victoria Anne Dowling, Mialy Fanjamalala Ramaroson
  • USE OF ALKALINE PHOSPHATASE FOR PRESERVING RENAL FUNCTION
    Publication number: 20190209662
    Abstract: The invention relates to the field of medicine and in particular to means and methods for preserving renal function after a treatment with a risk of reducing renal function. The present invention also relates to means and methods for shortening the duration of renal replacement therapy, increasing the creatinine clearance and decreasing the adverse effects of medicaments.
    Type: Application
    Filed: September 10, 2018
    Publication date: July 11, 2019
    Inventors: Jacques Salomon Robert Arend, Erik Jan Van Den Berg, Willem Raaben
  • Chimeric Alkaline Phosphatase-Like Proteins
    Publication number: 20190024062
    Abstract: The invention relates to improved alkaline phosphatases, pharmaceutical compositions comprising improved alkaline phosphatases and the use of improved alkaline phosphatases for preventing, treating or curing diseases.
    Type: Application
    Filed: February 7, 2018
    Publication date: January 24, 2019
    Applicant: AM-Pharma B.V.
    Inventors: Willem RAABEN, Luigi Johannes Cornelius JONK, Erik Jan VAN DEN BERG, Andrea VAN ELSAS, José Luis MILLÁN
  • Chimeric alkaline phosphatase-like proteins
    Patent number: 9926544
    Abstract: The invention relates to improved alkaline phosphatases, pharmaceutical compositions comprising improved alkaline phosphatases and the use of improved alkaline phosphatases for preventing, treating or curing diseases.
    Type: Grant
    Filed: January 26, 2015
    Date of Patent: March 27, 2018
    Assignee: AM-Pharma B.V.
    Inventors: Willem Raaben, Luigi Johannes Cornelius Jonk, Erik Jan Van Den Berg, Andrea Van Elsas, José Luis Millán
  • Downstream Processing of an Alkaline Phosphatase
    Publication number: 20170009217
    Abstract: The invention relates to the field of downstream processing (DSP) of an alkaline phosphatase (AP). More specifically, it relates to a method for reducing host cell protein content in a composition comprising AP. The invention further relates to a composition comprising an AP and a reduced content of a host cell protein.
    Type: Application
    Filed: January 26, 2015
    Publication date: January 12, 2017
    Applicant: AM-PHARMA B.V.
    Inventors: Luigi Johannes Cornelius JONK, Stephen Edward CONNER, Erik Jan VAN DEN BERG, Andrea VAN ELSAS, Abhinav Alok SHUKLA, Heather Bethea HORNE, Susan COOK, Timothy Martin KELLY, Victoria Anne DOWLING, Mialy Fanjamalala RAMAROSON
  • Chimeric Alkaline Phosphatase-Like Proteins
    Publication number: 20170009216
    Abstract: The invention relates to improved alkaline phosphatases, pharmaceutical compositions comprising improved alkaline phosphatases and the use of improved alkaline phosphatases for preventing, treating or curing diseases.
    Type: Application
    Filed: January 26, 2015
    Publication date: January 12, 2017
    Applicant: AM-Pharma B.V.
    Inventors: Willem RAABEN, Luigi Johannes Cornelius JONK, Erik Jan VAN DEN BERG, Andrea VAN ELSAS, José Luis MILLÁN
  • Use of Alkaline Phosphatase for Preserving Renal Function
    Publication number: 20160250299
    Abstract: The invention relates to the field of medicine and in particular to means and methods for preserving renal function after a treatment with a risk of reducing renal function. The present invention also relates to means and methods for shortening the duration of renal replacement therapy, increasing the creatinine clearance and decreasing the adverse effects of medicaments.
    Type: Application
    Filed: January 28, 2016
    Publication date: September 1, 2016
    Inventors: Jacques Salomon Robert AREND, Erik Jan Van Den Berg, Willem Raaben
  • The Use of Alkaline Phosphatase for Preserving Renal Function
    Publication number: 20140219984
    Abstract: The invention relates to the field of medicine and in particular to means and methods for preserving renal function after a treatment with a risk of reducing renal function. The present invention also relates to means and methods for shortening the duration of renal replacement therapy, increasing the creatinine clearance and decreasing the adverse effects of medicaments.
    Type: Application
    Filed: June 8, 2012
    Publication date: August 7, 2014
    Applicant: AM-PHARMA B.V.
    Inventors: Jacques Salomon Robert Arend, Erik Jan Van Den Berg, Willem Raaben